New views and possibilities of antidiabetic drugs in treating and/or preventing mild cognitive impairment and Alzheimer’s Disease

Kai Zhong(China Pharmaceutical University), Yu Zhu(Nanjing Medical University), Xuan Ke(China Pharmaceutical University), Su Su Tang(China Pharmaceutical University), Fang Chen(University of Saskatchewan), Yang Lv(China Pharmaceutical University), Hao Hong(China Pharmaceutical University)
Metabolic Brain Disease
April 6, 2018
10.1007/s11011-018-0227-1
Cited by 30

Related Papers

Recent progress of porcine milk components and mammary gland function
|Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology|2018|140
Antidiabetic drugs restore abnormal transport of amyloid-β across the blood–brain barrier and memory impairment in db/db mice
|Neuropharmacology|2015|135
Effects of Maternal and Fetal Characteristics on Cell-Free Fetal DNA Fraction in Maternal Plasma
|Reproductive Sciences|2015|105
Targeted inhibition of RAGE reduces amyloid-β influx across the blood-brain barrier and improves cognitive deficits in db/db mice
|Neuropharmacology|2017|81
Cysteinyl Leukotrienes and Their Receptors: Emerging Therapeutic Targets in Central Nervous System Disorders
|CNS Neuroscience & Therapeutics|2016|80